1 – 5 of 5
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Pain as bad as you can imagine or extremely severe pain? A randomized controlled trial comparing two pain scale anchors
(
- Contribution to journal › Article
-
Mark
Predictive value of kallikrein forms and β-microseminoprotein in blood from patients with evidence of detectable levels of PSA after radical prostatectomy
(
- Contribution to journal › Article
- 2022
-
Mark
Predicting Grade group 2 or higher cancer at prostate biopsy by 4Kscore in blood and uCaP microRNA model in urine
(
- Contribution to journal › Article
-
Mark
Independent validation of a pre-specified four-kallikrein marker model for prediction of adverse pathology and biochemical recurrence
(
- Contribution to journal › Article
- 2020
-
Mark
A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy
(
- Contribution to journal › Article